Search results
10 lip 2020 · Patients with meningiomas exhibit symptoms that continue well after treatment with fatigue and cognitive impairments as the most bothersome. Moreover, patients report key communication gaps that can be addressed to improve their disease experience and care.
21 mar 2021 · Abstract. Meningiomas are the most common intracranial tumor, making up more than a third of all primary central nervous system (CNS) tumors. They are mostly benign tumors that can be observed or preferentially treated with gross total resection that provides good outcomes.
13 gru 2021 · Meningiomas are typically benign and slow-growing, but these types of central nervous system tumors can become life-threatening. Franco DeMonte, M.D., shares what to know about diagnosis and treatment – and symptoms to watch for.
21 maj 2021 · The cornerstone for the diagnosis of meningioma is MRI, with a typical presentation as a well circumscribed dural lesion with homogeneous enhancing. 68-gallium-labeled somatostatin receptor analog (68 Ga-DOTATATE) could have a diagnostic role in detecting recurrence in irradiated meningiomas.
Introduction. The philosophy in the management of meningiomas is to treat the symptomatic or the growing tumours in order to preserve neurological function and / or to confirm diagnosis where uncertain. Management options include: Surgery. Radiotherapy . Radiological surveillance.
The meningioma task force of the European Association of Neuro-Oncology (EANO) assessed the scientific literature and composed a framework of the best possible evidence-based recommendations for health professionals. The provisional diagnosis of meningioma is mainly made by MRI.
These include diagnosis and managing side effects or symptoms. As these tumours are rare, there may not always be a relevant clinical trial happening. If there is, your doctor or nurse may ask you to think about taking part.
